Novartis AG (SWX:NOVN)
Switzerland · Delayed Price · Currency is CHF 133.08
-1.04 (-0.78%)
Nov 6, 2026, 5:30 PM CET
Novartis AG Market Cap
Novartis AG has a market cap or net worth of 251.34 billion as of November 6, 2026. It is the 46th most valuable company in the world and the 2nd biggest in Switzerland. Its market cap has increased by 28.95% in one year.
Market Cap
251.34B
Enterprise Value
284.52B
Revenue
47.86B
Global Rank
Country Rank
#2 Switzerland
PE Ratio
30.48
ChartMarket Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 186.69B to 251.34B, an increase of 34.63%. That is a compound annual growth rate of 1.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 251.34B | 19.51% |
| Dec 30, 2025 | 210.30B | 18.59% |
| Dec 30, 2024 | 177.34B | 1.66% |
| Dec 29, 2023 | 174.45B | -2.98% |
| Dec 30, 2022 | 179.80B | 0.12% |
| Dec 30, 2021 | 179.59B | -5.61% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 305.60B |
| Lonza Group AG | 45.89B |
| Galderma Group AG | 44.61B |
| Sandoz Group AG | 35.57B |
| Alcon | 29.53B |
| Sonova Holding AG | 16.97B |
| Straumann Holding AG | 16.50B |
| Bachem Holding AG | 5.87B |